GSK Expands Respiratory Pipeline With Aiolos Bio Buy

[ad_1] Updated Jan. 9, 2024 3:07 am ET GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows…

GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings

[ad_1] Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit rose mainly due to the U.S. launch of its Arexvy vaccine, although it…

FDA Approves GSK’s RSV Vaccine for Older Adults

[ad_1] Health Approval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says [ad_2] Source link

GSK 1Q Profit, Sales Beat Expectations But Fell On-Year; Backs 2023 Guidance

[ad_1] GSK confirmed its 2023 guidance after it reported first-quarter net profit and sales above expectations but that declined on year due to lower sales of Covid-19 treatments. [ad_2] Source…

Drugmakers Spent Freely in 2022 to Protect Revenue

[ad_1] Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics. [ad_2] Source link